Verrica Pharmaceuticals (VRCA) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to -$0.03.
- Verrica Pharmaceuticals' EPS (Weighted Average and Diluted) rose 9938.52% to -$0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was $11.37, marking a year-over-year increase of 21893.31%. This contributed to the annual value of -$1.43 for FY2024, which is 360.24% up from last year.
- As of Q3 2025, Verrica Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.03, which was up 9938.52% from $0.02 recorded in Q2 2025.
- Verrica Pharmaceuticals' 5-year EPS (Weighted Average and Diluted) high stood at $0.02 for Q2 2025, and its period low was -$4.88 during Q3 2024.
- For the 5-year period, Verrica Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$0.72, with its median value being -$0.33 (2021).
- In the last 5 years, Verrica Pharmaceuticals' EPS (Weighted Average and Diluted) crashed by 2633335.55% in 2023 and then soared by 10054.05% in 2025.
- Quarter analysis of 5 years shows Verrica Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.35 in 2021, then soared by 60.31% to -$0.14 in 2022, then crashed by 285.71% to -$0.54 in 2023, then soared by 51.55% to -$0.26 in 2024, then surged by 88.53% to -$0.03 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.03 for Q3 2025, versus $0.02 for Q2 2025 and -$0.1 for Q1 2025.